Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Oksana A. Shlobin"'
Autor:
Steven D. Nathan, Benham Tehrani, Qiong Zhao, Rafael Arias, Dennis Kim, Antonia Pellegrini, Ashley Claire Collins, Jack Diviney, Shourjo Chakravorty, Vikramjit Khangoora, Oksana A. Shlobin, Christopher Thomas, Ben R. Lavon, Christopher S. King, Abhimanyu Chandel
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary vascular dysfunction in the absence of pulmonary hypertension (PH) has been observed in patients with idiopathic pulmonary fibrosis (IPF). We describe the prevalence and etiology of elevated pulmonary vascular resistance (PVR) with
Externí odkaz:
https://doaj.org/article/0736e46afbbf4357b8d2aa58730cdf0c
Autor:
Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant morbidity and mortality. Until recently, the studies of pulmonary vasodilator therapy in
Externí odkaz:
https://doaj.org/article/9ed23c30ba194e9489b223bcf9cea4b7
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Connective tissue diseases (CTDs) can be associated with various forms of pulmonary hypertension, including pulmonary arterial hypertension (PAH), pulmonary veno‐occlusive disease, pulmonary venous hypertension, interstitial lung disease
Externí odkaz:
https://doaj.org/article/8215f65d4bd845aea4c2d1c51eca3986
Autor:
Shameek K. Gayen, Robert P. Baughman, Steven D. Nathan, Athol U. Wells, Vasilis Kouranos, Esam H. Alhamad, Daniel A. Culver, Joseph Barney, Eva M. Carmoma, Francis C. Cordova, Marloes Huitema, Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Surinder S. Birring, Laura C. Price, Stephen J. Wort, Oksana A. Shlobin, Rohit Gupta
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Pulmonary hypertension (PH) is a risk factor for mortality in patients with sarcoidosis. Severe PH in chronic lung disease has previously been defined as mean pulmonary arterial pressure (mPAP) ≥ 35 mmHg or mPAP 25 ≥ mmHg with cardiac in
Externí odkaz:
https://doaj.org/article/bc4ee1dfe8b84f39af2bd487660885c1
Autor:
Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e18618- (2023)
Rationale and objectives: Lung transplantation is a potentially life-saving treatment option for patients with idiopathic pulmonary fibrosis (IPF); however, not all eligible candidates get referred and listed for transplantation. Amongst IPF patients
Externí odkaz:
https://doaj.org/article/8c37b2bb0a4644b09df9db233129b2fc
Autor:
Franck F. Rahaghi, Vivien M. Hsu, Robert J. Kaner, Maureen D. Mayes, Ivan O. Rosas, Rajan Saggar, Virginia D. Steen, Mary E. Strek, Elana J. Bernstein, Nitin Bhatt, Flavia V. Castelino, Lorinda Chung, Robyn T. Domsic, Kevin R. Flaherty, Nishant Gupta, Bashar Kahaleh, Fernando J. Martinez, Lee E. Morrow, Teng Moua, Nina Patel, Oksana A. Shlobin, Brian D. Southern, Elizabeth R. Volkmann, Dinesh Khanna
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-16 (2023)
Abstract Background Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for 20–40% of mortality. Evolution of therapeutic option
Externí odkaz:
https://doaj.org/article/f0f7c08666254d739a6ca421ab557bf3
Autor:
Abhimanyu Chandel, Christopher S. King, Rosalinda V. Ignacio, Jean Pastre, Oksana A. Shlobin, Vikramjit Khangoora, Shambhu Aryal, Alan Nyquist, Anju Singhal, Kevin R. Flaherty, Steven D. Nathan
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background The Distance-Oxygen-Gender-Age-Physiology (DO-GAP) index has been shown to improve prognostication in idiopathic pulmonary fibrosis (IPF) compared to the Gender-Age-Physiology (GAP) score. We sought to externally validate the DO-GAP index
Externí odkaz:
https://doaj.org/article/7c8101c0afb5466fa82b90bd7a1441cb
Autor:
Paul Forfia, Raymond Benza, Michele D'Alto, Teresa De Marco, Jean M. Elwing, Robert Frantz, Francois Haddad, Ronald Oudiz, Ioana R. Preston, Stephan Rosenkranz, John Ryan, Robert Schilz, Oksana A. Shlobin, Jean‐Luc Vachiery, Carmine Dario Vizza, Anton Vonk Noordegraaf, Margaret R. Sketch, Meredith Broderick, Vallerie McLaughlin
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Right heart (RH) structure and function are major determinants of symptoms and prognosis in pulmonary arterial hypertension (PAH). RH imaging provides detailed information, but evidence and guidelines on the use of RH imaging in treatment de
Externí odkaz:
https://doaj.org/article/ce8abfb9f6ab4b669e83e51505d50fe2
Autor:
Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John Wort
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD). Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in association with many other forms of ILD. Associated pathog
Externí odkaz:
https://doaj.org/article/73b2d7d3068442c48437e55307419645
Autor:
Jasleen Minhas, Sai Prasanna Narasimmal, Todd M. Bull, Teresa De Marco, John Wesley McConnell, Matthew R. Lammi, Thenappan Thenappan, Jeremy P. Feldman, Jeffrey S. Sager, David B. Badesch, John J. Ryan, Daniel C. Grinnan, Dianne Zwicke, Evelyn M. Horn, Jean M. Elwing, John E. Moss, Michael Eggert, Oksana A. Shlobin, Robert P. Frantz, Sonja D. Bartolome, Stephen C. Mathai, Sula Mazimba, Steven C. Pugliese, Nadine Al‐Naamani, PHAR investigators
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-11 (2021)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, morbid, potentially curable subtype of pulmonary hypertension that negatively impacts health‐related quality of life (HRQoL). Little is known about differences in HRQoL and hospitaliz
Externí odkaz:
https://doaj.org/article/7630fe6521244aa0b6585bc803767e68